vs
Apellis Pharmaceuticals, Inc.（APLS）与RLJ Lodging Trust（RLJ）财务数据对比。点击上方公司名可切换其他公司
RLJ Lodging Trust的季度营收约是Apellis Pharmaceuticals, Inc.的1.6倍（$328.6M vs $199.9M），RLJ Lodging Trust净利率更高（0.1% vs -29.5%，领先29.6%），RLJ Lodging Trust同比增速更快（-0.4% vs -5.9%），RLJ Lodging Trust自由现金流更多（$117.4M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 0.6%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
RLJ集团是美国企业家罗伯特·路易斯·约翰逊创办的资产管理企业。约翰逊在2001年出售自己一手创立的黑人娱乐电视台后，于马里兰州贝塞斯达成立了这家公司。集团业务覆盖酒店不动产投资、私募股权投资、金融服务、资产管理、保险、汽车经销、文体娱乐以及电子彩票 gaming 等多个领域，总部设于贝塞斯达。
APLS vs RLJ — 直观对比
营收规模更大
RLJ
是对方的1.6倍
$199.9M
营收增速更快
RLJ
高出5.5%
-5.9%
净利率更高
RLJ
高出29.6%
-29.5%
自由现金流更多
RLJ
多$131.7M
$-14.3M
两年增速更快
APLS
近两年复合增速
0.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $328.6M |
| 净利润 | $-59.0M | $430.0K |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 0.2% |
| 净利率 | -29.5% | 0.1% |
| 营收同比 | -5.9% | -0.4% |
| 净利润同比 | -62.2% | -92.0% |
| 每股收益（稀释后） | $-0.40 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSRLJ
| Q4 25 | $199.9M | $328.6M | ||
| Q3 25 | $458.6M | $330.0M | ||
| Q2 25 | $178.5M | $363.1M | ||
| Q1 25 | $166.8M | $328.1M | ||
| Q4 24 | $212.5M | $330.0M | ||
| Q3 24 | $196.8M | $345.7M | ||
| Q2 24 | $199.7M | $369.3M | ||
| Q1 24 | $172.3M | $324.4M |
净利润APLSRLJ
| Q4 25 | $-59.0M | $430.0K | ||
| Q3 25 | $215.7M | $-3.7M | ||
| Q2 25 | $-42.2M | $28.5M | ||
| Q1 25 | $-92.2M | $3.4M | ||
| Q4 24 | $-36.4M | $5.4M | ||
| Q3 24 | $-57.4M | $20.6M | ||
| Q2 24 | $-37.7M | $37.1M | ||
| Q1 24 | $-66.4M | $4.9M |
营业利润率APLSRLJ
| Q4 25 | -25.6% | 0.2% | ||
| Q3 25 | 48.7% | -1.0% | ||
| Q2 25 | -18.6% | 8.0% | ||
| Q1 25 | -50.0% | 1.1% | ||
| Q4 24 | -12.3% | 1.8% | ||
| Q3 24 | -24.0% | 6.1% | ||
| Q2 24 | -14.7% | 10.2% | ||
| Q1 24 | -36.0% | 1.6% |
净利率APLSRLJ
| Q4 25 | -29.5% | 0.1% | ||
| Q3 25 | 47.0% | -1.1% | ||
| Q2 25 | -23.6% | 7.8% | ||
| Q1 25 | -55.3% | 1.0% | ||
| Q4 24 | -17.1% | 1.6% | ||
| Q3 24 | -29.2% | 6.0% | ||
| Q2 24 | -18.9% | 10.0% | ||
| Q1 24 | -38.5% | 1.5% |
每股收益（稀释后）APLSRLJ
| Q4 25 | $-0.40 | $-0.05 | ||
| Q3 25 | $1.67 | $-0.07 | ||
| Q2 25 | $-0.33 | $0.15 | ||
| Q1 25 | $-0.74 | $-0.02 | ||
| Q4 24 | $-0.30 | $-0.01 | ||
| Q3 24 | $-0.46 | $0.09 | ||
| Q2 24 | $-0.30 | $0.20 | ||
| Q1 24 | $-0.54 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $410.2M |
| 总债务越低越好 | — | $2.2B |
| 股东权益账面价值 | $370.1M | $2.2B |
| 总资产 | $1.1B | $4.7B |
| 负债/权益比越低杠杆越低 | — | 1.01× |
8季度趋势，按日历期对齐
现金及短期投资APLSRLJ
| Q4 25 | $466.2M | $410.2M | ||
| Q3 25 | $479.2M | $374.8M | ||
| Q2 25 | $370.0M | $373.9M | ||
| Q1 25 | $358.4M | $347.5M | ||
| Q4 24 | $411.3M | $409.8M | ||
| Q3 24 | $396.9M | $385.4M | ||
| Q2 24 | $360.1M | $371.1M | ||
| Q1 24 | $325.9M | $350.2M |
总债务APLSRLJ
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | $93.1M | $2.2B |
股东权益APLSRLJ
| Q4 25 | $370.1M | $2.2B | ||
| Q3 25 | $401.2M | $2.2B | ||
| Q2 25 | $156.3M | $2.2B | ||
| Q1 25 | $164.2M | $2.2B | ||
| Q4 24 | $228.5M | $2.3B | ||
| Q3 24 | $237.1M | $2.3B | ||
| Q2 24 | $264.3M | $2.3B | ||
| Q1 24 | $266.7M | $2.3B |
总资产APLSRLJ
| Q4 25 | $1.1B | $4.7B | ||
| Q3 25 | $1.1B | $4.8B | ||
| Q2 25 | $821.4M | $4.8B | ||
| Q1 25 | $807.3M | $4.8B | ||
| Q4 24 | $885.1M | $4.9B | ||
| Q3 24 | $901.9M | $4.9B | ||
| Q2 24 | $904.5M | $4.9B | ||
| Q1 24 | $831.9M | $4.9B |
负债/权益比APLSRLJ
| Q4 25 | — | 1.01× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 0.96× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | 0.35× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $243.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $117.4M |
| 自由现金流率自由现金流/营收 | -7.1% | 35.7% |
| 资本支出强度资本支出/营收 | 0.1% | 38.5% |
| 现金转化率经营现金流/净利润 | — | 566.97× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $186.6M |
8季度趋势，按日历期对齐
经营现金流APLSRLJ
| Q4 25 | $-14.2M | $243.8M | ||
| Q3 25 | $108.5M | $63.3M | ||
| Q2 25 | $4.4M | $101.3M | ||
| Q1 25 | $-53.4M | $16.3M | ||
| Q4 24 | $19.4M | $285.4M | ||
| Q3 24 | $34.1M | $80.1M | ||
| Q2 24 | $-8.3M | $113.5M | ||
| Q1 24 | $-133.0M | $20.8M |
自由现金流APLSRLJ
| Q4 25 | $-14.3M | $117.4M | ||
| Q3 25 | $108.3M | $33.6M | ||
| Q2 25 | $4.4M | $66.1M | ||
| Q1 25 | $-53.4M | $-30.5M | ||
| Q4 24 | $19.3M | $148.9M | ||
| Q3 24 | — | $45.4M | ||
| Q2 24 | $-8.4M | $74.9M | ||
| Q1 24 | $-133.3M | $-13.0M |
自由现金流率APLSRLJ
| Q4 25 | -7.1% | 35.7% | ||
| Q3 25 | 23.6% | 10.2% | ||
| Q2 25 | 2.5% | 18.2% | ||
| Q1 25 | -32.0% | -9.3% | ||
| Q4 24 | 9.1% | 45.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | -4.2% | 20.3% | ||
| Q1 24 | -77.3% | -4.0% |
资本支出强度APLSRLJ
| Q4 25 | 0.1% | 38.5% | ||
| Q3 25 | 0.0% | 9.0% | ||
| Q2 25 | 0.0% | 9.7% | ||
| Q1 25 | 0.0% | 14.3% | ||
| Q4 24 | 0.0% | 41.4% | ||
| Q3 24 | 0.0% | 10.0% | ||
| Q2 24 | 0.0% | 10.4% | ||
| Q1 24 | 0.2% | 10.4% |
现金转化率APLSRLJ
| Q4 25 | — | 566.97× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | 3.56× | ||
| Q1 25 | — | 4.85× | ||
| Q4 24 | — | 53.09× | ||
| Q3 24 | — | 3.89× | ||
| Q2 24 | — | 3.06× | ||
| Q1 24 | — | 4.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
RLJ
| Occupancy | $262.1M | 80% |
| Food And Beverage | $41.9M | 13% |
| Hotel Other | $24.6M | 7% |
